Who owns NURIX THERAPEUTICS INC?
- Ticker: NRIX
- CUSIP Number: 67080m103
Tip: Access positions for across all investors
Analyze quarterly positions in Nurix Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Nurix Therapeutics stock
Who bought or sold NURIX THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
Trv Gp Iii | 5.4M | $178M | 0% | Dec 2020 | ||
Column Group | 5.4M | $177M | 100% | Dec 2020 | ||
Redmile Group | 2.8M | $94M | 10% | Dec 2020 | ||
Wellington Management Company | 2.4M | $80M | -27% | Dec 2020 | ||
Foresite Capital Management IV | 2.3M | $77M | 0% | Dec 2020 | ||
Baker Bros. Advisors | 1.8M | $59M | 0% | Dec 2020 | ||
EcoR1 Capital | 1.5M | $51M | 30% | Dec 2020 | ||
Bain Capital Life Sciences Investors | 1.3M | $42M | 0% | Dec 2020 | ||
Boxer Capital | 1.2M | $40M | -10% | Dec 2020 | ||
BlackRock | 1.2M | $39M | 75% | Dec 2020 | ||
Eventide Asset Management | 1.1M | $35M | 111% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Nurix Therapeutics? |
||||||
Ponoi Management | 686k | $23M | 100% | Dec 2020 | ||
Ponoi II Management | 686k | $23M | 100% | Dec 2020 | ||
Vanguard Group | 618k | $20M | 15% | Dec 2020 | ||
T. Rowe Price Associates | 592k | $20M | 5% | Dec 2020 | ||
Foresite Capital Management V | 452k | $15M | 100% | Dec 2020 | ||
State Street Corporation | 451k | $15M | 243% | Dec 2020 | ||
FMR | 336k | $11M | 0% | Dec 2020 | ||
Harvard Management Company | 315k | $10M | 0% | Dec 2020 | ||
OrbiMed Advisors | 300k | $9.9M | 0% | Dec 2020 | ||
Rock Springs Capital Management | 257k | $8.5M | 0% | Dec 2020 | ||
Logos Global Management | 230k | $7.6M | -16% | Dec 2020 | ||
Geode Capital Management | 199k | $6.6M | 8% | Dec 2020 | ||
Jennison Associates | 198k | $6.5M | -1% | Dec 2020 | ||
Woodline Partners | 161k | $5.3M | 12% | Dec 2020 | ||
Goldman Sachs Group | 160k | $5.2M | 100% | Dec 2020 | ||
Northern Trust | 138k | $4.5M | 3% | Dec 2020 | ||
Ameriprise Financial | 129k | $4.2M | -50% | Dec 2020 | ||
Millennium Management | 113k | $3.7M | 100% | Dec 2020 | ||
Nuveen Asset Management | 99k | $3.3M | 48% | Dec 2020 | ||
Charles Schwab Investment Management | 77k | $2.5M | 6% | Dec 2020 | ||
Avidity Partners Management | 50k | $1.6M | 0% | Dec 2020 | ||
Wells Fargo & Company | 48k | $1.6M | 35% | Dec 2020 | ||
Bank of New York Mellon | 44k | $1.5M | 59% | Dec 2020 | ||
TD Asset Management | 38k | $1.2M | 0% | Dec 2020 | ||
Swiss National Bank | 25k | $825k | 100% | Dec 2020 | ||
CalPERS | 25k | $811k | -2% | Dec 2020 | ||
Credit Suisse | 18k | $569k | 100% | Dec 2020 | ||
California State Teachers Retirement System | 18k | $579k | 5% | Dec 2020 | ||
State of Wisconsin Investment Board | 16k | $516k | 100% | Dec 2020 | ||
Deutsche Bank Aktiengesellschaft | 13k | $431k | 120% | Dec 2020 | ||
DekaBank Deutsche Girozentrale | 12k | $465k | 100% | Dec 2020 | ||
Rhumbline Advisers | 12k | $382k | 22% | Dec 2020 | ||
Victory Capital Management | 11k | $356k | -4% | Dec 2020 | ||
New York State Common Retirement Fund | 10k | $343k | 65% | Dec 2020 | ||
Citadel Advisors | 9.2k | $302k | -96% | Dec 2020 | ||
Morgan Stanley | 8.8k | $289k | 409% | Dec 2020 | ||
ProShare Advisors | 8.6k | $282k | 100% | Dec 2020 | ||
Susquehanna Fundamental Investments | 8.3k | $273k | -8% | Dec 2020 | ||
Bank of America Corporation | 7.3k | $242k | -15% | Dec 2020 | ||
Manufacturers Life Insurance Company | 7.0k | $231k | 18% | Dec 2020 | ||
Laurion Capital Management | 7.0k | $230k | 0% | Dec 2020 | ||
American International | 6.8k | $223k | 2% | Dec 2020 | ||
Jpmorgan Chase & Co | 5.2k | $172k | 26% | Dec 2020 | ||
MetLife Investment Advisors | 5.1k | $167k | 0% | Dec 2020 | ||
Citigroup | 3.5k | $116k | 559% | Dec 2020 | ||
Metropolitan Life Insurance Company | 3.5k | $115k | 0% | Dec 2020 | ||
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.8k | $92k | 0% | Dec 2020 | ||
Tower Research Capital | 2.6k | $86k | 46% | Dec 2020 | ||
Bank Of Montreal | 1.8k | $73k | 254% | Dec 2020 | ||
Legal & General Group | 1.7k | $55k | 35% | Dec 2020 | ||
Pacer Advisors | 1.6k | $49k | 193% | Mar 2021 | ||
Summit Investment Advisors | 946.00 | $31k | 0% | Dec 2020 | ||
Penserra Capital Management | 890.00 | $29k | 100% | Dec 2020 | ||
Ensign Peak Advisors | 799.00 | $26k | 0% | Dec 2020 | ||
Great-West Life Assurance Company | 640.00 | $21k | 100% | Dec 2020 | ||
Royal Bank of Canada | 405.00 | $13k | 305% | Dec 2020 | ||
Daiwa Securities Group | 73.00 | $2.0k | 100% | Dec 2020 |
Who sold out of Nurix Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Weiss Multi-strategy Advisers | Sep 2020 | 52k | $1.8M |
EAM Global Investors | Sep 2020 | 50k | $1.8M |
Caas Capital Management | Sep 2020 | 40k | $1.4M |
Eudaimonia Asset Management | Sep 2020 | 35k | $1.2M |
Davidson Kempner Capital Management | Sep 2020 | 25k | $868k |
Sphera Funds Management | Sep 2020 | 23k | $785k |
Marshall Wace North America | Sep 2020 | 15k | $524k |
Marshall Wace Asia | Sep 2020 | 14k | $485k |
Pentwater Capital Management | Sep 2020 | 10k | $349k |
Teachers Retirement System Of The State Of Kentucky | Sep 2020 | 7.6k | $265k |
Mirabella Financial Services | Sep 2020 | 6.9k | $240k |